143 related articles for article (PubMed ID: 38817645)
1. Assessment of post-myocardial infarction lipid levels and management: Results from a tertiary care hospital of Pakistan.
Rauf R; Soomro MI; Khan MN; Kumar M; Soomro NA; Kazmi KA
World J Cardiol; 2024 May; 16(5):282-292. PubMed ID: 38817645
[TBL] [Abstract][Full Text] [Related]
2. A Retrospective Study on the Adoption of Lipid Management Guidelines in Post-Myocardial Infarction Patients in a Tertiary Care Centre.
Wambua PM; Khan Z; Kariuki CM; Ogola EN
Cureus; 2023 Jul; 15(7):e41402. PubMed ID: 37546064
[TBL] [Abstract][Full Text] [Related]
3. Dyslipidemia treatment and attainment of LDL-cholesterol treatment goals in patients participating in the Managed Care for Acute Myocardial Infarction Survivors program.
Nowowiejska-Wiewióra A; Wita K; Mędrala Z; Tomkiewicz-Pająk L; Bujak K; Mizia-Stec K; Brzychczy P; Gąsior M; Gąsior Z; Kulbat A; Kalarus Z; Wojakowski W; Trzeciak P; Witkowski A; Banach M; Legutko J
Kardiol Pol; 2023; 81(4):359-365. PubMed ID: 36871294
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Low-density Lipoprotein Cholesterol Target Attainment Rates According to the 2016 and 2019 European Society of Cardiology/European Atherosclerosis Society Dyslipidemia Guidelines for Secondary Prevention in Patients with Acute Myocardial Infarction.
Şimşek B; İnan D; Çınar T; Cagdas-Yumurtaş A; Ozan-Tanık V; Zeren G; İlker-Avcı İ; Yücel-Karabay C; Güngör B; Tokgozoğlu L
Rev Invest Clin; 2021 Nov; 73(3):371-378. PubMed ID: 34098569
[TBL] [Abstract][Full Text] [Related]
5. Intensive lipid-lowering therapy for early achievement of guideline-recommended LDL-cholesterol levels in patients with ST-elevation myocardial infarction ("Jena auf Ziel").
Makhmudova U; Samadifar B; Maloku A; Haxhikadrija P; Geiling JA; Römer R; Lauer B; Möbius-Winkler S; Otto S; Schulze PC; Weingärtner O
Clin Res Cardiol; 2023 Sep; 112(9):1212-1219. PubMed ID: 36602598
[TBL] [Abstract][Full Text] [Related]
6. Target-attainment rates of low-density lipoprotein cholesterol using lipid-lowering drugs one year after acute myocardial infarction in sweden.
Hambraeus K; Lindhagen L; Tydén P; Lindahl B; Lagerqvist B
Am J Cardiol; 2014 Jan; 113(1):17-22. PubMed ID: 24169006
[TBL] [Abstract][Full Text] [Related]
7. Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol? : a retrospective study.
Wongcharoen W; Sutthiwutthichai S; Gunaparn S; Phrommintikul A
BMC Cardiovasc Disord; 2017 Jan; 17(1):10. PubMed ID: 28056802
[TBL] [Abstract][Full Text] [Related]
8. Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study-Rationale and design of the PACMAN-AMI trial.
Zanchin C; Koskinas KC; Ueki Y; Losdat S; Häner JD; Bär S; Otsuka T; Inderkum A; Jensen MRJ; Lonborg J; Fahrni G; Ondracek AS; Daemen J; van Geuns RJ; Iglesias JF; Matter CM; Spirk D; Juni P; Mach F; Heg D; Engstrom T; Lang I; Windecker S; Räber L
Am Heart J; 2021 Aug; 238():33-44. PubMed ID: 33951415
[TBL] [Abstract][Full Text] [Related]
9. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
Rosenblit PD
Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.
Aydin MU; Aygul N; Altunkeser BB; Unlu A; Taner A
Atherosclerosis; 2015 Apr; 239(2):439-43. PubMed ID: 25697576
[TBL] [Abstract][Full Text] [Related]
11. Use of Statin and Target Low-density lipoprotein cholesterol attainment among post-ST elevation myocardial infarction patients in Shahid Gangalal National Heart Centre, Kathmandu, Nepal.
Adhikari CM; Prajapati D; Timalsena B; Bogati A; Khan B; Safi S; Adhikari J; Ghimire V
J Nepal Health Res Counc; 2024 Mar; 21(4):564-572. PubMed ID: 38616584
[TBL] [Abstract][Full Text] [Related]
12. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
13. Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol.
Lee KH; Jeong MH; Kim HM; Ahn Y; Kim JH; Chae SC; Kim YJ; Hur SH; Seong IW; Hong TJ; Choi DH; Cho MC; Kim CJ; Seung KB; Chung WS; Jang YS; Rha SW; Bae JH; Cho JG; Park SJ;
J Am Coll Cardiol; 2011 Oct; 58(16):1664-71. PubMed ID: 21982310
[TBL] [Abstract][Full Text] [Related]
14. Achievement of LDL-cholesterol goal with statins after an st segment elevation myocardial infarction.
Tungsubutra W; Phongtuntakul B
J Med Assoc Thai; 2015 Feb; 98(2):129-36. PubMed ID: 25842792
[TBL] [Abstract][Full Text] [Related]
15. Optimal low-density lipoprotein cholesterol target level in Korean acute myocardial infarction patients (<70 mg/dL vs. <55 mg/dL): Based on Korea acute myocardial infarction registry-National Institute of Health.
Ahn JH; Ahn Y; Jeong MH; Kim JH; Hong YJ; Sim DS; Kim MC; Cho KH; Hyun DY; Lee SH; Kim HS; Gwon HC; Seong IW; Hur SH; Oh SK
Int J Cardiol; 2022 Mar; 351():15-22. PubMed ID: 34921900
[TBL] [Abstract][Full Text] [Related]
16. Improvement of low-density lipoprotein cholesterol target achievement rates through cardiac rehabilitation for patients after ST elevation myocardial infarction or non-ST elevation myocardial infarction in Germany: Results of the PATIENT CARE registry.
Schwaab B; Zeymer U; Jannowitz C; Pittrow D; Gitt A
Eur J Prev Cardiol; 2019 Feb; 26(3):249-258. PubMed ID: 30509144
[TBL] [Abstract][Full Text] [Related]
17. Lipid Profile of Patients with Acute Myocardial Infarction (AMI).
Kumar N; Kumar S; Kumar A; Shakoor T; Rizwan A
Cureus; 2019 Mar; 11(3):e4265. PubMed ID: 31139524
[TBL] [Abstract][Full Text] [Related]
18. Short-Course High-Intensity Statin Treatment during Admission for Myocardial Infarction and LDL-Cholesterol Reduction-Impact on Tailored Lipid-Lowering Therapy at Discharge.
Marcos-Garcés V; Merenciano-González H; Martínez Mas ML; Palau P; Climent Alberola JI; Perez N; López-Bueno L; Esteban Argente MC; Valls Reig M; Muñoz Alcover R; Pradillas Contreras I; Arizón Benito A; Payá Rubio A; Ríos-Navarro C; de Dios E; Gavara J; Chorro FJ; Sanchis J; Bodi V
J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202134
[TBL] [Abstract][Full Text] [Related]
19. Benefits of Statin Therapy in Patients With Acute Myocardial Infarction With Serum Low-Density Lipoprotein Cholesterol ≤ 50 mg/dl.
Piao ZH; Jin L; Kim JH; Ahn Y; Kim YJ; Cho MC; Kim CJ; Kim HS; Liu B; Jeong MH;
Am J Cardiol; 2017 Jul; 120(2):174-180. PubMed ID: 28532771
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
